Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 16, Pages 4233
Publisher
MDPI AG
Online
2021-08-23
DOI
10.3390/cancers13164233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The direct and indirect regulation of follicular T helper cell differentiation in inflammation and cancer
- (2021) Yejin Cao et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment
- (2021) María Belén Giorello et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial
- (2021) Thomas Bachelot et al. NATURE MEDICINE
- Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
- (2021) Eric P Winer et al. LANCET ONCOLOGY
- Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
- (2021) N.E. Donlon et al. CANCER LETTERS
- Novel approaches to target the microenvironment of bone metastasis
- (2021) Lorenz C. Hofbauer et al. Nature Reviews Clinical Oncology
- Cancer‐associated fibroblasts: Key players in shaping the tumor immune microenvironment
- (2021) Mélanie Desbois et al. IMMUNOLOGICAL REVIEWS
- PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer
- (2021) Hope S Rugo et al. JNCI-Journal of the National Cancer Institute
- Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers
- (2020) Dominique Yuan Bin Seow et al. BREAST CANCER RESEARCH AND TREATMENT
- Virtual multiplex immunohistochemistry: Application on cell block of effusion and aspiration cytology
- (2020) Ronald C. K. Chan et al. DIAGNOSTIC CYTOPATHOLOGY
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
- (2020) HYUN LEE et al. ANTICANCER RESEARCH
- Dual anti-CTLA-4 and anti-PD-1 blockade in metaplastic carcinoma of the breast: Dart (SWOG S1609, Cohort 36).
- (2020) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
- (2020) Ozge Saatci et al. Nature Communications
- An Attempt to Polarize Human Neutrophils Toward N1 and N2 Phenotypes in vitro
- (2020) Mareike Ohms et al. Frontiers in Immunology
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer
- (2020) Nicola Gaynor et al. SEMINARS IN CANCER BIOLOGY
- Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients
- (2020) Nicolas Gonzalo Núñez et al. Nature Communications
- Emerging CAR-T Cell Therapy for the Treatment of Triple Negative Breast Cancer
- (2020) Sundee Dees et al. MOLECULAR CANCER THERAPEUTICS
- Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
- (2020) Gagan K. Gupta et al. Cancers
- TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up
- (2020) Ewan Millar et al. Cancers
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
- (2020) Javier Cortes et al. LANCET
- Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
- (2020) Yeon Hee Park et al. Nature Communications
- Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells
- (2020) Nicholas M. Clark et al. Cell Reports
- Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
- (2019) Zhanhuai Wang et al. Cell Communication and Signaling
- Interaction of tumor-associated macrophages and cancer chemotherapy
- (2019) Irina Larionova et al. OncoImmunology
- Tumor-Associated Neutrophils in Cancer: Going Pro
- (2019) Wu et al. Cancers
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review
- (2019) Planes-Laine et al. Cancers
- Metastatic breast carcinoma-associated fibroblasts have enhanced pro-tumorigenic properties related to increased IGF2 expression.
- (2019) Yirui Gui et al. CLINICAL CANCER RESEARCH
- The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
- (2019) Lea Monteran et al. Frontiers in Immunology
- Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer
- (2019) Mi Jeong Kwon ARCHIVES OF PHARMACAL RESEARCH
- B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
- (2019) Daniel P. Hollern et al. CELL
- Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer
- (2019) Bum-Sup Jang et al. RADIOTHERAPY AND ONCOLOGY
- Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy
- (2019) Sung Pil Hong et al. Nature Communications
- Tumor-reprogrammed resident T cells resist radiation to control tumors
- (2019) Ainhoa Arina et al. Nature Communications
- Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
- (2018) Marie Beguinot et al. BMC CANCER
- The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome
- (2018) H. Arias-Pulido et al. BREAST CANCER RESEARCH AND TREATMENT
- Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
- (2018) Ana Costa et al. CANCER CELL
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer
- (2018) Tamara Muliaditan et al. CLINICAL CANCER RESEARCH
- Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy
- (2018) Ariel E. Marciscano et al. CLINICAL CANCER RESEARCH
- Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer
- (2018) Yi Cui et al. CLINICAL CANCER RESEARCH
- Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
- (2018) Hope S. Rugo et al. CLINICAL CANCER RESEARCH
- HALO-109–301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancer
- (2018) Gary J Doherty et al. Future Oncology
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Pre- and Posttreatment Breast Cancers in the SWOG S0800 Phase II Neoadjuvant Chemotherapy Trial
- (2018) Vasiliki Pelekanou et al. MOLECULAR CANCER THERAPEUTICS
- Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- (2018) Peter Savas et al. NATURE MEDICINE
- LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy
- (2018) Leonie Rossow et al. ONCOGENE
- Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
- (2018) Matthew A. Lakins et al. Nature Communications
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images
- (2018) Joel Saltz et al. Cell Reports
- New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms
- (2018) Meng Shen et al. Frontiers in Immunology
- Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness
- (2018) Maximilian Boesch et al. OncoImmunology
- Immunological differences between primary and metastatic breast cancer
- (2018) B Szekely et al. ANNALS OF ONCOLOGY
- Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
- (2018) Si-Qi Qiu et al. CANCER TREATMENT REVIEWS
- Tumor-associated macrophages: CD206 and CD68 expression and patient outcomes in locally advanced breast cancer.
- (2018) Chelsea Nicole Williams et al. JOURNAL OF CLINICAL ONCOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy
- (2018) Tiziana Triulzi et al. OncoImmunology
- Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- CCL1 is a major regulatory T cell attracting factor in human breast cancer
- (2018) Benjamin Kuehnemuth et al. BMC CANCER
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- Minimal Increases in Tumor Infiltrating Lymphocytes Despite Excellent Tumor Responses after Pre-Operative Accelerated Partial Breast Irradiation in Early Stage ER+ Breast Cancer Patients
- (2018) C. Bergom et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade
- (2018) Silvia C. Formenti et al. NATURE MEDICINE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
- (2018) Michael Bartoschek et al. Nature Communications
- Tumour radiosensitivity is associated with immune activation in solid tumours
- (2017) Tobin Strom et al. EUROPEAN JOURNAL OF CANCER
- CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer
- (2017) Mikhail Buldakov et al. IMMUNOBIOLOGY
- Tumor-associated macrophages in human breast cancer parenchyma negatively correlate with lymphatic metastasis after neoadjuvant chemotherapy
- (2017) Irina Mitrofanova et al. IMMUNOBIOLOGY
- Cytokine profile of breast cell lines after different radiation doses
- (2017) Valentina Bravatà et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
- (2017) Evette S. Radisky et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer
- (2017) Andreas Heindl et al. JNCI-Journal of the National Cancer Institute
- Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers
- (2017) Xia Liu et al. ONCOLOGIST
- Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
- (2017) François Bertucci et al. Current Oncology Reports
- Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer
- (2017) Andreas Heindl et al. JNCI-Journal of the National Cancer Institute
- An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes
- (2016) Ahrong Kim et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Tumor microenvironment-mediated chemoresistance in breast cancer
- (2016) Kobra velaei et al. BREAST
- Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast
- (2016) Michael J. Campbell et al. BREAST CANCER RESEARCH AND TREATMENT
- Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer
- (2016) V. Varadan et al. CLINICAL CANCER RESEARCH
- Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
- (2016) Malte Mohme et al. Nature Reviews Clinical Oncology
- Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients
- (2016) Eva K. Sage et al. RADIOTHERAPY AND ONCOLOGY
- Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication
- (2016) Samantha Burugu et al. Breast Cancer
- CD8+tumor-infiltrating lymphocytes contribute to spontaneous “healing” in HER2-positive ductal carcinoma in situ
- (2016) Michi Morita et al. Cancer Medicine
- Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes
- (2015) Hee Jin Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer
- (2015) Hee Jin Lee et al. JOURNAL OF CLINICAL PATHOLOGY
- Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs
- (2015) Sharad K. Sharma et al. JOURNAL OF IMMUNOLOGY
- Role of the Tumor Microenvironment in Breast Cancer
- (2015) Savas D. Soysal et al. PATHOBIOLOGY
- The lymph node microenvironment and its role in the progression of metastatic cancer
- (2015) Ethel R. Pereira et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells
- (2015) Andreas Ritter et al. Oncotarget
- Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration
- (2015) Tiziana Triulzi et al. Oncotarget
- Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells
- (2015) Maria Peiris-Pagès et al. Oncotarget
- Progressive loss of anti-HER2 CD4+T-helper type 1 response in breast tumorigenesis and the potential for immune restoration
- (2015) Jashodeep Datta et al. OncoImmunology
- Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
- (2014) H. R. Ali et al. ANNALS OF ONCOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands
- (2014) Pinar Karasar et al. BREAST CANCER RESEARCH AND TREATMENT
- Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
- (2014) Mirjam C. Boelens et al. CELL
- Multiplexed Quantitative Analysis of CD3, CD8, and CD20 Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2014) J. R. Brown et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Connecting Fibrosis and Solid Tumor Metastasis
- (2014) T. R. Cox et al. CLINICAL CANCER RESEARCH
- Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
- (2014) Bernardo Tavora et al. NATURE
- Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers
- (2013) S. Shafaq Mujtaba et al. ANNALS OF SURGICAL ONCOLOGY
- The metastatic microenvironment of breast cancer: Clinical implications
- (2013) R.E. Coleman et al. BREAST
- The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer
- (2013) S. Muenst et al. BREAST CANCER RESEARCH AND TREATMENT
- The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
- (2013) Z M A Mohammed et al. BRITISH JOURNAL OF CANCER
- Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer
- (2013) A N Seo et al. BRITISH JOURNAL OF CANCER
- LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis
- (2013) T. R. Cox et al. CANCER RESEARCH
- Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells
- (2013) Hirotomo Harimoto et al. IMMUNOLOGY AND CELL BIOLOGY
- Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
- (2013) Hee Jin Lee et al. Journal of Breast Cancer
- CD4+ follicular helper T cell infiltration predicts breast cancer survival
- (2013) Chunyan Gu-Trantien et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Tumour oxygenation: implications for breast cancer prognosis
- (2013) H. Rundqvist et al. JOURNAL OF INTERNAL MEDICINE
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- Immune Regulatory Function of B Cells
- (2012) Claudia Mauri et al. Annual Review of Immunology
- Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+tumor infiltrating lymphocytes in ductal and lobular breast cancers
- (2012) Raoul Droeser et al. BMC CANCER
- Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
- (2012) Elizabeth S. Nakasone et al. CANCER CELL
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells
- (2012) Patsy S H Soon et al. ENDOCRINE-RELATED CANCER
- Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer
- (2012) Rin Yamaguchi et al. HUMAN PATHOLOGY
- CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms
- (2012) Wei Bin Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The radiosensitivity of endothelial cells isolated from human breast cancer and normal tissue in vitro
- (2012) Moon-Taek Park et al. MICROVASCULAR RESEARCH
- HSP70 Enhances Immunosuppressive Function of CD4+CD25+FoxP3+ T Regulatory Cells and Cytotoxicity in CD4+CD25− T Cells
- (2012) Julian Wachstein et al. PLoS One
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition
- (2011) Gali Soria et al. BMC CANCER
- The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin
- (2011) Osvaldo Pontiggia et al. BREAST CANCER RESEARCH AND TREATMENT
- The prognostic significance of lymphovascular invasion in invasive breast carcinoma
- (2011) Emad A. Rakha et al. CANCER
- Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
- (2011) P. B. Olkhanud et al. CANCER RESEARCH
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Role of cancer-associated fibroblasts in breast cancer development and prognosis
- (2011) Abdelilah Aboussekhra INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Cross-talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro
- (2011) Cara F. Buchanan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tumour-infiltrating macrophages and clinical outcome in breast cancer
- (2011) S M A Mahmoud et al. JOURNAL OF CLINICAL PATHOLOGY
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- Leukocyte composition of human breast cancer
- (2011) B. Ruffell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FDA Pulls Approval for Avastin in Breast Cancer
- (2011) Cancer Discovery
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Tremelimumab in Combination with Exemestane in Patients with Advanced Breast Cancer and Treatment-Associated Modulation of Inducible Costimulator Expression on Patient T Cells
- (2010) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- Radiation Enhances Regulatory T Cell Representation
- (2010) Evelyn L. Kachikwu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
- (2010) B. H. Nelson JOURNAL OF IMMUNOLOGY
- Jekyll and Hyde: the role of the microenvironment on the progression of cancer
- (2010) Michael Allen et al. JOURNAL OF PATHOLOGY
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
- (2010) Subhra K Biswas et al. NATURE IMMUNOLOGY
- Radiation-induced cell death mechanisms
- (2010) David Eriksson et al. TUMOR BIOLOGY
- Angiogenesis and Breast Cancer
- (2010) Adhemar Longatto Filho et al. Journal of Oncology
- Plasmacytoid Dendritic Cells
- (2009) Armin G. Jegalian et al. ADVANCES IN ANATOMIC PATHOLOGY
- Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy
- (2009) Eugenio Maiorano et al. BREAST CANCER RESEARCH AND TREATMENT
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
- (2009) D. Generali et al. CLINICAL CANCER RESEARCH
- Lymphangiogenesis and cancer metastasis
- (2009) Viviane Mumprecht et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
- (2009) Pierre Farmer et al. NATURE MEDICINE
- 1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
- (2008) C. C. Park et al. CANCER RESEARCH
- Breast Carcinoma-Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes
- (2008) N. M. Hawsawi et al. CANCER RESEARCH
- Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
- (2008) S. Ladoire et al. CLINICAL CANCER RESEARCH
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’
- (2008) Sandra Collette et al. EUROPEAN JOURNAL OF CANCER
- Stromal gene expression predicts clinical outcome in breast cancer
- (2008) Greg Finak et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started